SEC Company Response from Vincerx Pharma, Inc. (VINC) (CIK 0001796129) (VINC) — Jan 26, 2022
Vincerx Pharma, Inc. (VINC) (CIK 0001796129)
Date: Jan. 26, 2022 · CIK: 0001796129 · Accession: 0001193125-22-018007
AI Filing Summary & Sentiment
File numbers found in text: 333-262239
Letter
VINCERX PHARMA, INC.
260 Sheridan Avenue, Suite 400
Palo Alto, CA 94306
January 26, 2022
VIA FACSIMILE AND EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Vincerx Pharma, Inc. - Registration Statement – Form S-3
File No. 333-262239
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Vincerx Pharma, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement on Form S-3 (File No. 333-262239) (the “Registration Statement”) be declared effective on January 28, 2022, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Gabriella A. Lombardi and Julie Park of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, to make such request on its behalf. The Registrant hereby also authorizes Gabriella A. Lombardi and Julie Park of Pillsbury Winthrop Shaw Pittman LLP to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Gabriella A. Lombardi of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, at (650) 233-4670, or in her absence, Julie Park at (650) 233-4067.
[Signature Page Follows]
Sincerely,
VINCERX PHARMA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VINCERX PHARMA, INC. 260 Sheridan Avenue, Suite 400 Palo Alto, CA 94306 January 26, 2022 VIA FACSIMILE AND EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Vincerx Pharma, Inc. - Registration Statement – Form S-3 File No. 333-262239 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Vincerx Pharma, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement on Form S-3 (File No. 333-262239) (the “Registration Statement”) be declared effective on January 28, 2022, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Gabriella A. Lombardi and Julie Park of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, to make such request on its behalf. The Registrant hereby also authorizes Gabriella A. Lombardi and Julie Park of Pillsbury Winthrop Shaw Pittman LLP to orally modify or withdraw this request for acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Gabriella A. Lombardi of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, at (650) 233-4670, or in her absence, Julie Park at (650) 233-4067. [Signature Page Follows] Sincerely, VINCERX PHARMA, INC. By: /s/ Dr. Raquel E. Izumi Dr. Raquel E. Izumi President and Chief Operations Officer cc: Tom C. Thomas Gabriella A. Lombardi Julie Park